Enzyme–substrate reporters for evaluation of substrate specificity of HIF prolyl hydroxylase isoforms


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

An organism naturally responds to hypoxia via stabilization of hypoxia-inducible factor (HIF). There are three isoforms of HIFα subunits whose stability is regulated by three isozymes of HIF prolyl hydroxylase (PHD1-3). Despite intense studies on recombinant enzyme isoforms using homogeneous activity assay, there is no consensus on the PHD iso-form preference for the HIF isoform as a substrate. This work provides a new approach to the problem of substrate specificity using cell-based reporters expressing the enzyme and luciferase-labeled substrate pair encoded in the same expression vector. The cell is used as a microbioreactor for running the reaction between the overexpressed enzyme and substrate. Using this novel approach, no PHD3 activity toward HIF3 was demonstrated, indirectly pointing to the hydroxylation of the second proline in 564PYIP567 (HIF1) catalyzed by this isozyme. The use of “paired” enzyme–substrate reporters to evaluate the potency of “branched tail” oxyquinoline inhibitors of HIF PHD allows higher precision in revealing the optimal structural motif for each enzyme isoform.

About the authors

A. I. Osipyants

Rogachev National Medical Research Center for Pediatric Hematology, Oncology and Immunology

Email: igazaryan@gmail.com
Russian Federation, Moscow, 117997

N. A. Smirnova

Rogachev National Medical Research Center for Pediatric Hematology, Oncology and Immunology

Email: igazaryan@gmail.com
Russian Federation, Moscow, 117997

A. Yu. Khristichenko

Rogachev National Medical Research Center for Pediatric Hematology, Oncology and Immunology

Email: igazaryan@gmail.com
Russian Federation, Moscow, 117997

D. M. Hushpulian

Rogachev National Medical Research Center for Pediatric Hematology, Oncology and Immunology

Email: igazaryan@gmail.com
Russian Federation, Moscow, 117997

S. V. Nikulin

Rogachev National Medical Research Center for Pediatric Hematology, Oncology and Immunology

Email: igazaryan@gmail.com
Russian Federation, Moscow, 117997

T. A. Chubar

Lomonosov Moscow State University, Chemistry Faculty

Email: igazaryan@gmail.com
Russian Federation, Moscow, 119991

A. A. Zakhariants

Innovations and High Technologies MSU Ltd.

Email: igazaryan@gmail.com
Russian Federation, Moscow, 109451

V. I. Tishkov

Lomonosov Moscow State University, Chemistry Faculty; Innovations and High Technologies MSU Ltd.

Email: igazaryan@gmail.com
Russian Federation, Moscow, 119991; Moscow, 109451

I. G. Gazaryan

Rogachev National Medical Research Center for Pediatric Hematology, Oncology and Immunology; Lomonosov Moscow State University, Chemistry Faculty

Author for correspondence.
Email: igazaryan@gmail.com
Russian Federation, Moscow, 117997; Moscow, 119991

A. A. Poloznikov

Rogachev National Medical Research Center for Pediatric Hematology, Oncology and Immunology

Email: igazaryan@gmail.com
Russian Federation, Moscow, 117997


Copyright (c) 2017 Pleiades Publishing, Ltd.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies